Sanofi Consumer Healthcare India has reported 1% rise in net profit to Rs 46.35 crore on a 6.8% increase in net sales to Rs 170.70 crore in Q3 FY25 as compared with Q3 FY24.

The deal will see Germany's Boehringer pay Sanofi €4.7 billion as part of the deal, with Merial valued at €11.4 billion and its global consumer health (CHC) division – except its business in ...

The FDA granted orphan designation to Sanofi (SNY) US Services’ rilzabrutinib as a treatment of autoimmune hemolytic anemia, according to a post to the agency’s website. Published first on ...

Sanofi (NASDAQ:SNY) has entered a share purchase agreement in relation to the sale of a 50% controlling stake in Opella, its consumer healthcare business, to private equity firm CD&R. The terms of ...

Sanofi Consumer Healthcare India Q4 Results 2025:Sanofi Consumer Healthcare India declared their Q4 results on 20 Feb, 2025. The topline decreased by 20.53% year-over-year (YoY), with profit ...

This month on pharmaphorum, we explore the history of French pharmaceutical company Sanofi, which was created through many partnerships and acquisitions over a period of 100 years. Sanofi is one ...

US-headquartered CHC Helicopter has been awarded five contracts with Brazilian oil giant Petrobras, further bolstering operations in the South American nation. Petrobras often approaches the ...

Sanofi Consumer Healthcare India Ltd share price was down by 0.00% from the previous closing price of ₹4,706.90. Who are peers of Sanofi Consumer Healthcare India Ltd? The peers of Sanofi ...